Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroplant (St. John’s wort) vs placebo in adolescent mild to moderate MDD
DRKS00000287Phase 4Terminated
- Sponsor
- University Hospital Ulm
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Neuroplant (St. John’s wort) with Placebo (2 arms). Primary endpoint: Efficacy in mild to moderate major depressive disorder. Started Dec 2009; status: terminated.
02
Drugs
hypericum extract WS 5570
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on DRKS00000287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000287.